Advanced search
Publication Cover
Journal of Chemotherapy Volume 2, 1990 - Issue 5
Submit an article Journal homepage
2
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Comparative In- Vitro Activity of Piperacillin and Piperacillin Plus Tazobactam Towards Beta-Lactamase Producing Clinical Isolates

S. StefaniInstitute of Microbiology, University of Catania and Institute of Hygiene, University of Sassari, Italy.
,
P. Castiglia
,
A. Maida
,
E. Muresu
,
M.L. MezzatestaInstitute of Microbiology, University of Catania and Institute of Hygiene, University of Sassari, Italy.
&
G. NicolettaInstitute of Microbiology, University of Catania and Institute of Hygiene, University of Sassari, Italy.
Pages 295-299 | Published online: 14 Jul 2016

References

  • Abeles RH, Maycock AL. Suicide enzyme inactivators. Acct Chem Res 1976; 9: 313–319.
  • Aswapokee N, Neu HC. A sulfone, beta-lactam compound which acts as a beta-lactamase inhibitor. J Antibiot 1978; 31: 1238–1243.
  • Jones RN. In vitro evaluation of aminopenicillin-betalactamase inhibitor combinations. Drugs 1988; 36 (suppl. 7): 17–26.
  • Ishida N, Higashitani F, Hanehara C, Uji T, Inque M, Mitsuhashi S. In vitro evaluation of new beta-lactamase inhibitor: YTR 830H and derivatives. J Chemother 1989; 1 (suppl. 4): 88–89.
  • Chin NX, Neu HC. In vitro activity of YTR-830H in combination with beta-lactamase unstable beta-lactams. J Chemother 1989; 1 (suppl. 4): 90–92.
  • Kuck NA, Petersen PJ, Weiss WJ, Jacobus NV, Testa RT, Tally FP. Synergistic activity of piperacillin: YTR-830H combinations in vitro and in vivo. J Chemother 1989; 1 (suppl. 4): 105–106.
  • Lennette EH, Balows A, Hansler W Jr, Truant JP. Manual of Clinical Microbiology 4th ed. Washington DC: American Society for Microbiology, 1985.
  • Jorgensen JM, Redding JS, Maher LH, Howell AW Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae. J Clin Microbiol 1987; 25: 2105–2113.
  • Jacobs MR, Aronoff SC, Johenning S, Yamaze S. Comparative activities of the beta-lactamase inhibitor YTR 830, clavulanate sulbactam combined with extended spectrum penicillins against ticarcillin-resistant Enterobacteriacee and Pseudomonads. J Antimicrob Chemother 1986; 18: 177–184.
  • New HC. The role of beta-lactamase inhibitors in chemotherapy. Pharmac Ther 1985; 30: 1–18.
  • Boyce JM, Medeiros AA. Role of beta-lactamase in expression of resistance by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1987; 31: 1426–1428.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.